method for predicting whether a patient with wet diarrhea is more likely to benefit from treatment with a high affinity anti-vegf antibody and kit for predicting whether a patient with wet diarrhea is more likely to benefit from treatment with ranibizumab

摘要

The application relates to methods for determining whether a patient is at increased risk of developing wet AMD or whether a patient has an increased likelihood of benefiting from treatment with a high-affinity anti-VEGF antibody.